A phase II study of S-1 in combination with sorafenib in metastatic renal cell carcinoma

被引：0
|
作者：
Sakai, Hideki
Ohba, Kojiro
Hashine, Katsuyoshi
Tomita, Yoshihiko
Shinohara, Nobuo
Fujisawa, Masato
Eto, Masatoshi
Ozono, Seiichiro
Tsukamoto, Taiji
Akaza, Hideyuki
Naito, Seiji
机构：
[1] Nagasaki Univ, Dpartment Nephrourol, Grad Sch Biomed Sci, Nagasaki 852, Japan
[2] Natl Hosp Org Shikoku Canc Ctr, Dept Urol, Matsuyama, Ehime, Japan
[3] Yamagata Univ, Sch Med, Dept Urol, Yamagata 99023, Japan
[4] Hokkaido Univ, Dept Urol, Grad Scohool Med, Sapporo, Hokkaido, Japan
[5] Kobe Univ, Dept Urol, Grad Sch Med, Kobe, Hyogo 657, Japan
[6] Kumamoto Univ, Dept Urol, Fac Life Sci, Kumamoto, Japan
[7] Hamamatsu Univ Sch Med, Dept Urol, Hamamatsu, Shizuoka 4313192, Japan
[8] Sapporo Med Univ, Dept Urol, Sch Med, Sapporo, Hokkaido, Japan
[9] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan
[10] Kyushu Univ, Dept Urol, Grad Sch Med Sci, Fukuoka 812, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.529
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
529
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma
    Naito, S.
    Sakai, H.
    Hashine, K.
    Tomita, Y.
    Shinohara, N.
    Fujisawa, M.
    Eto, M.
    Ozono, S.
    Akaza, H.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1871 - 1876
  • [2] A phase I study of S-1 in combination with sorafenib in metastatic renal cell carcinoma (mRCC).
    Ozono, Seiichiro
    Takayama, Tatsuya
    Fujisawa, Masato
    Miyake, Hideaki
    Hashine, Katsuyoshi
    Ninomiya, Iku
    Tatsugami, Katsunori
    Sakai, Hideki
    Ohba, Kojiro
    Akaza, Hideyuki
    Tsukamoto, Taiji
    Naito, Seiji
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [3] A phase II study of S-1 for the treatment of cytokine-refractory metastatic renal cell carcinoma
    Naito, S.
    Eto, M.
    Shinohara, N.
    Tomita, Y.
    Fujisawa, M.
    Namiki, M.
    Nishikido, M.
    Usami, M.
    Tsukamoto, T.
    Akaza, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
    Rini, Brian I.
    Wilding, George
    Hudes, Gary
    Stadler, Walter M.
    Kim, Sinil
    Tarazi, Jamal
    Rosbrook, Brad
    Trask, Peter C.
    Wood, Laura
    Dutcher, Janice P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4462 - 4468
  • [5] A Phase 1 Study of Everolimus and Sorafenib for Metastatic Clear Cell Renal Cell Carcinoma
    Harzstark, Andrea L.
    Small, Eric J.
    Weinberg, Vivian K.
    Sun, Janine
    Ryan, Charles J.
    Lin, Amy M.
    Fong, Lawrence
    Brocks, Dion R.
    Rosenberg, Jonathan E.
    CANCER, 2011, 117 (18) : 4194 - 4200
  • [6] Final Results of a Phase II Study of S-1 in Patients with Cytokine-refractory Metastatic Renal Cell Carcinoma
    Naito, Seiji
    Tatsugami, Katsunori
    Shinohara, Nobuo
    Tomita, Yoshihiko
    Mizokami, Atsushi
    Fujisawa, Masato
    Hashine, Katsuyoshi
    Nishikido, Masaharu
    Nakagawa, Masayuki
    Tsukamoto, Taiji
    Akaza, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (02) : 122 - 126
  • [7] A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma
    Yoshihiko Ooka
    Tetsuhiro Chiba
    Sadahisa Ogasawara
    Kuniaki Arai
    Eiichiro Suzuki
    Akinobu Tawada
    Tatsuya Yamashita
    Fumihiko Kanai
    Shuichi Kaneko
    Osamu Yokosuka
    Investigational New Drugs, 2014, 32 : 723 - 728
  • [8] A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma
    Ooka, Yoshihiko
    Chiba, Tetsuhiro
    Ogasawara, Sadahisa
    Arai, Kuniaki
    Suzuki, Eiichiro
    Tawada, Akinobu
    Yamashita, Tatsuya
    Kanai, Fumihiko
    Kaneko, Shuichi
    Yokosuka, Osamu
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 723 - 728
  • [9] Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma
    Lee, Su Jin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Kang, Won Ki
    Lee, Jongtae
    Yim, Dong-Seok
    Lim, Ho Yeong
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1540 - 1547
  • [10] Multicenter Phase II Trial of S-1 in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Naito, Seiji
    Eto, Masatoshi
    Shinohara, Nobuo
    Tomita, Yoshihiko
    Fujisawa, Masato
    Namiki, Mikio
    Nishikido, Masaharu
    Usami, Michiyuki
    Tsukamoto, Taiji
    Akaza, Hideyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5022 - 5029
12345